'Institute for Brain Research, University of Zurich, Switzerland and *Regeneron Pharmaceuticals, Inc., Tarrytown, New York 10591 Wrapping and compaction of myelin sheaths around axons require specific membrane and membrane-associated proteins. Transmembrane proteins like proteolipid protein (PLP), the peripheral myelin protein 22 (PMP-22) and P, as well as myelin basic protein (MBP) are crucial for this process. We have isolated a rat cDNA, initially denominated NS 3, that is mainly expressed in the myelinating cells of the nervous system, the oligodendrocytes and Schwann cells. The cDNA encodes a highly hydrophobic protein of 16.8 kDa with four putative transmembrane domains. The putative NS 3 protein lacks a N-terminal hydrophobic leader sequence and has no consensus sequence for N-linked glycosylation.
In contrast to PLP and PMP-22, the first and third putative transmembrane domain of the NS 3 protein contain charged amino acids, a feature which resembles the structure of gap junction proteins. Sequence analysis showed that NS 3 is the rat homolog of a human gene called MAL that was cloned from, and is expressed in various T-cell lines. Therefore, we call this gene rMAL (rat MAL). In the nervous system, the expression of rMAL, mFlNA begins after birth and is highest during myelination. In situ hybridization shows that rMAL mRNA is exclusively expressed in white and gray matter oligodendrocytes in the CNS and in myelinating During myelination the specialized plasma membrane of myelin forming cells wraps around the axons and is subsequently compacted. This task is performed in the CNS by oligodendrocytes and in the PNS by Schwann cells (for review, see Doyle and Colman, 1993) . Specific membrane and membrane-associated proteins are required for (1) the initial contact between the proliferating oligodendrocytes or Schwann cells and the axons, (2) for the spiral wrapping of the processes around the axon, and (3) for the transport system for ions and essential molecules between the myelin lamellae (for review, see Hudson, 1990) . The proteins that are thought to be involved in the process of wrapping and compaction are adhesion proteins such as myelin associated glycoprotein (MAG; for review, see Salzer et al., 1990) , oligodendrocyte-myelin glycoprotein (OMgp; Mikol et al., 1990 ) and the myelin protein P, (Filbin et al., 1990) , hydrophobic proteins like proteolipid protein (PLP; for review see Nave and Milner, 1989 ) and peripheral myelin protein 22 (PMP-22; for review, see Suter et al., 1993) and membrane-associated cytoplasmic proteins like myelin basic protein (MBP; for review, see Moscarello et al., 1989) . The most abundant myelin protein in the CNS is PLP (for review, see Mikoshiba et al., 1991) , a 28 kDa protein that is not glycosylated and is thought to consist of four transmembrane domains (Milner et al., 1985; Popot et al., 1991, for review) . In the PNS, PMP-22 (Welcher et al., 1991) is a 22 kDa protein that also consists of four hydrophobic domains but is glycosylated (Snirpes et al., 1992) . Both proteins lack a cleaved signal peptide. Mutations in the transmembrane domains of PLP will lead to hypomyelinations as it is known for the PLP gene in the rumpshaker and the jimpy mouse (Schneider et al., 1992) , in the myelin deficient rat (Boison and Stoffel, 1989) , and in the human Pelizaeus-Merzbacher disease (Hudson et al., 1989) . The mutation in the trembler mouse, which is characterized by peripheral nerve demyelination, could be correlated to point mutations in the PMP-22 gene. Mutations in the same gene are the cause of the hereditary human peripheral neuropathy Charcot-Marie-Tooth type 1A (CMTlA; Suter et al., 1992) . Recently, two additional genetic defects which cause a demyelinating type of CMT disease, type 1B and X, could be linked to a mutation in the gene for P,,, the most abundant protein in the peripheral myelin (Hayasaka et al., 1993) , and in the gene for the gap junction protein connexin 32 (Cx32; Bergoffen et al., 1993) . Cx32 belongs to the connexin superfamily class I (Bennett et al., 1991) or p group (Gimlich et al., 1988) which is expressed in various cell types including oligodendrocytes and Schwann cells (Bergoffen et al., 1993; Dermietzel and Spray, 1993) . Cx32 is a hydrophobic protein of 26-28 kD that has no leader sequence and no glycosylation site and consists correspond to putative membrane-spanning domains. B, Amino acid sequence (one letter code) comparison of human MAL (top sequence) and rat NS 3 (bottom sequence). Identical residues are indicated by solid vertical lines, and conservative amino acid substitutions are shown by colons. C, Hydrophobicity plot of rat MAL. The hydrophobicity index was calculated using the algorithm of Kyte and Doolittle (1982) . D, Hypothetical model of rat MAL protein based on secondary structure analysis and the model for human MAL by Alonso and Weissman (1987) . Tbe position of charged amino acids (at neutral pH) are indicated for positively (dark gray) and negatively (bright gray) charged amino acids. The putative transmembrane sequences I, III, and IV are predicted to be a-helical, whereas transmembrane domain II forms a B-sheet. Note that in this model, the N-and C-termini are on the cytoplasmic side of the membrane .   A   1   61   121   181   241   301   361   421   481   541  601  661  721  781  841  901   961  1021  1081   1141  1201  1261  1321  1381  1441  1501  1561  1621  1681  1741  1801  1861  1921  1981  2041  2101  2161   CGGAGCCGGAGGCGAGCTTGTCCAGTTCCAACGCCAGCCAGCTCGCAGGCATGGCCCCAGCAGC  M  A  P  A  A   AGCTTCGGGTGGCAGCACCCTGCCCAGTGGCTTCTCCGTCTTCGTCACCTTCCCTGACTT  A  S  G  G  S  TLPSGFSVFVTFPDL   GCTCTTCATCTTTGAGTTTATCTTTGGAGGCCTGGTGTGGATCCTGATCGCCTCCTCCCT  L  F  I  F  E  F  I  FGGLVWIL  I  A  S of four transmembrane domains. A single gap junction channel includes a dodecamer formed by six monomers of connexin in each membrane which are coupled together. The gap junction channel permits passage of small molecules up to about 1 kDa in size. The third transmembrane domain has conserved polar, basic and acidic groups which may form an amphipathic helix in which the polar side (glutamine) forms the aqueous channel (for review, see Bennett et al., 1991) .
By a differential screening approach described in detail in Schaeren-Wiemers et al. (1995) , we have identified a gene, tentatively denominated NS 3, which is in the nervous system exclusively expressed in oligodendrocytes and Schwann cells. Here we describe the characterization of this gene, its relationship to the human gene MAL, its structural relationship to the four-hydrophobic domain proteins PLP PMP-22, and connexin 32, its developmental expression in the CNS and PNS and evidences by A cDNA library constructed in lambda ZAP II (Stratagene) from postnatal day 16 spinal cord was differentially screened for oligodendrocyte-specific genes (Schaeren-Wiemers et al., 1995) . One of tbe isolated cDNA clones, denominated NS 3, represented a full length sequence of 2187 bp. Sequence analysis was performed by using the ABI 373A DNA sequencer-and Taq Dyedeoxy Terminator Cvcle Sequencing Kit (Annlied Biosvstems. Inc.. Foster Citv. CA). The NS3 sequence has-been submitted to EMBL,'accession number X82557.
Northern blot analysis. Total cellular RNA was isolated by the LiClprecipitation method described by Bothwell et al. (1990) electrophoresed &rough denaturing 1% formaldehyde gels, and transferred to ZETAProbe nvlon membranes (Bio-Rad) in 10X SSC (1 X SSC: 0.15 M NaCl. 0.05 M Na-citrate; pH 7.0). Hybridization was carried out in 0. phosphate buffer (pH 7.2), 7% SDS, 1% BSA, 1 mM EDTA, 20 p&ml denatured salmon sperm DNA (Mahmoudi and Lin, 1989) with 0.5 to 1 million dpm of Pzz-labeled cDNA probe per milliliter of hybridization buffer over night at 60°C. Filters were washed 3 times in 0.1 X SSC, 0.1% SDS at 60°C and subsequently exposed to Kodak XAR x-ray film at -80°C with intensifying screen. P'2-labeled cDNA probes were generated by random hexamer priming (Boehringer Mannheim kit).
In situ hybridization with digoxigenin-labeled cRNA probes. Synthetic riboprobes (cRNA) were generated from the whole sequence of the Bluescript containing cDNA inserts from both sides with T3 or T7 RNA polymerase, leading to antisense and sense (control) cRNA probes. The labeled cRNA probes were then alkali hydrolyzed to an average length of 200-400 bases. Digoxigenin-labeled antisense and sense cRNA probes were tested in Northern analysis for their specificity. In situ hybridization was performed on cryosections (15 pm thick) of fresh frozen tissue according to the protocol of Schaeren-Wiemers and Gerfin-Moser (1993). The color reaction time for the alkaline phosphatase reaction was about 18 hr (except for 2 d in newborn tissue).
Preparation of anti-rMAL antiserum. Based on the predicted primary amino acid sequence of rMAL (NS 3), two peptide sequences were selected from the two possible hydrophilic regions: peptide 1, HGGET-SWITLDAAYH (amino acids 79-93), and peptide 2, MFDGFTYR-HYHEN (amino acids 114-126). Synthesis of peptides and immunization of rabbits (two rabbits for each peptide) were performed using the MAP method (Posnett et al., 1988; Tam, 1988) by Research Genetics (Huntsville, AL).
Immunohistochemistry. Immunohistochemistry for the rMAL protein was performed on 4% paraformaldehyde-fixed tissue. Serial sections (25 urn thick) were cut in the sagittal plane for the brain and in the transversal plane for the spinal cord and sciatic nerve. Sections were immersed for 25 min in ice-cold 95% ethanol, 5% acidic acid, rehydrated into phosphate buffer (PBS) and residual protein binding sites were blocked by a 1 hr incubation in PBS containing 0.2% BSA-C, 0.1% cold water fish gelatine (both from Aurion, Wageningen, NL), 2.5% normal goat serum, and 0.05% saponin (Sigma). Anti-peptide 2 antiserum was used at a dilution of 1:200 and incubated overnight at 4°C. The secondary anti-rabbit biotinylated antibody (Vector) was used at a dilution of 1:lOO and incubated for .2 hr at room temperature. The staining patterns were revealed with the ABC method (Vector ABC kit) according to the manufacturer's instructions, with diaminobenzidine (DAB) as the chromogen. Sections were embedded and analyzed on an Olympus Vanox-T microscope.
For immunohistochemistry after in situ hybridization a polyclonal antibody against MBP (kindly provided by Dr. J.-M. Matthieu, Lausanne) was used at a dilution of 1:250, incubated over night at 4°C. The secondary antibody (anti rabbit-RITC, Jackson, West Grove, PA) was used at a dilution of 1: 100 and incubated for 1 hr at room temperature. The Hoechst dye 33286 (1 mg/ml in methanol, Calbiochem) was diluted 1:lOO and applied between the washing steps after the secondary antibody. Sections were embedded in Kaiser's gelatin (Merck) and analyzed as described above.
Immunoblot analysis. CNS myelin protein was prepared as described in Caroni and Schwab (1988) and separated on 15% SDS-polyacrylamide gels. The gels were fixed in 40% methanol, 10% acetic acid for 10 min, incubated for 30 min in 1% SDS, 48 mu Tris, 39 mM glycine, 20% methanol with several changes. The proteins were transferred to Immobilon-P membranes (Millipore) by semidry electrophoresis at room temperature for 1.5 hr at 74 V in 48 mu Tris buffer containing 39 mu glycine, 0.037% SDS, 20% methanol. The membranes were rinsed in PBS, and additional protein binding sites were blocked by a 1 hr incubation in PBS containing 3% BSA. Anti-peptide 2 antiserum was used at a dilution of I:500 and incubated overnight at 4°C in PBS with 3% BSA. The secondary anti-rabbit alkaline phosphatase-coupled antibody (Jackson, West Grove, PA) was used at a dilution of I:5000 and incubated for 2 hr at room temperature. After three rinses of PBS the bound alkaline phosphatase was localized using BCIP (5-bromo-4-chloro-3-indolylphosphate p-toluidine) and NBT (nitroblue tetrazolium chloride) as substrates.
Results

Isolation of rMAL cDNA clone
We differentially screened a postnatal day 16 rat spinal cord cDNA library for clones that hybridized with a probe derived from normal spinal cord but did not hybridize with a probe derived from spinal cord which was free of oligodendrocytes (Schaeren-Wiemers et al., 1995) . The known myelin genes MBP, PLP MAG, and CNPase were also subtracted. Cross-hybridization analysis and Northern blot analysis revealed several genes which were either exclusively expressed by oligodendrocytes or by oligodendrocytes and Schwann cells. One of these cDNA clones, denominated NS 3, revealed a 2.2 kb transcript which is expressed in spinal cord and in sciatic nerve. The 2187 bp cDNA sequence contains a 47 bp untranslated region at the 5' end, a 461 bp open reading frame coding for a 153 amino acid protein, and a 1681 bp 3' noncoding region (Fig. 1A) . Comparison of the cDNA sequence to the EMBL GeneBank data base showed that the NS 3 mRNA is likely to be the rat homolog of the previously described gene MAL which was isolated from a human T-lymphocyte cell line (Alonso and Weissman, 1987) . Both sequences show an overall homology of 80% at the nucleotide level in the open reading frame and the 5' untranslated region. The human MAL mRNA has a size of 1 kb and lacks the 1.2 kb 3' noncpding region of the rat sequence. The two predicted protein sequences are 89% identical and by adding conservative exchanges 95% similar (Fig. l@ . Therefore, NS 3 is denominated rat MAL (rMAL). phobicity plots and secondary structure prediction the amino acid residues X-41, 55-71, 93-109, and 129-145 represent putative transmembrane segments (Fig. lA,C) . The N-terminal sequence does no1 contain a cleavable signal sequence. There is no consensus site for N-linked glycosylation. This is supported by the fact that in vitro translation from the full length cDNA revealed a discrete band of an apparent mass of 16 kDa on SDS polyacrylamide gels (data not shown). The apparent molecular weight was not altered by adding microsomal membranes allowing potential posttranslational modifications such as cleaving of signal peptide and glycosylation (data not shown). Figure 1D shows the proposed model for the orientation of the rMAL protein which is adapted from the model of Alonso and Weissman (1987) for human MAL. The first and third putative transmembrane domain contain charged amino acids, a feature which is typical for membrane proteins forming pores such as gap junction proteins of the connexin superfamily (for review, see Bennett et al., 1991) and for ion channels such as the neurotransmitter receptor superfamily (for review, see Unwin, 1989 ). These two domains of the rat and human MAL protein are highly conserved (97% identical) whereas the other two domains are less conserved (80% identical; Fig. 1B ). Although structural similarities of rMAL to PLP, PMP-22, and connexin are evident, no significant sequence homologies could be detected, either to this set of proteins, or to other proteins included in the database.
rMAL mRNA is mainly expressed in the nervous system and peaks during myelination Northern analysis of different tissues of the adult rat demonstrated that MAL mRNA is predominantly expressed in the highly myelinated regions of the nervous system such as spinal cord, brainstem and developing sciatic nerve, with lower expression levels in the cerebellum and cerebral cortex ( Fig. 2A) . A weaker signal could be seen in spleen and in kidney. No detectable signal was found in heart, testis, lung, muscle, liver, and thymus.
To determine the developmental time course of rMAL mRNA expression, Northern blot analysis of different developmental stages during spinal cord development was performed (Fig. 2B) . rMAL transcripts became detectable first after birth and were most highly expressed during the initial three postnatal weeks, when oligodendrocytes are very active in myelinating axons. In the adult spinal cord rMAL mRNA was expressed at a lower level. This expression pattern corresponded to the expression pattern of transcripts of other myelin-associated proteins such as CNPase, MBP (Fig. 2B) or PLP (Zeller et al., 1984; Hudson et al., 1987; Jordan et al., 1989) . In the developing sciatic nerve rMAL mRNA was much more highly expressed than in the CNS with an expression level comparable to that of MBP mRNA ( 
MBP
In the nervous system, rMAL mRNA is exclusively expressed by oligodendrocytes and Schwann cells Myelin formation starts at birth in the ventral and dorsal funiculi in the cervical part of the rat spinal cord (Rozeik and Keyserlingk, 1987; Schwab and Schnell, 1989) . Myelination in the PNS starts shortly before birth (Mirsky and Jessen, 1990) . To determine the localization of rMAL mRNA and its expression pattern during development in oligodendrocytes and Schwann cells, we performed in situ hybridization on sections of brain, spinal cord, and peripheral nerves of animals of various ages. The rMAL mRNA expression pattern was compared to that of MBP mRNA, which is already expressed before birth (unpublished data), and MBP protein (by immunofluorescence), a marker for myelination that is expressed after birth (Rozeik and Keyserlingk, 1987; Schwab and Schnell, 1989) .
At birth, rMAL mRNA is expressed in Schwann cells but not in oligodendrocytes
In situ hybridization was performed on cross sections of the vertebral column dissected with the adjacent muscle tissue, dorsal roots, sympathetic ganglia, and their peripheral nerves of newborn rat pups (Fig. 3A) . MBP mRNA is already expressed in oligodendrocytes in the ventral and dorsal white matter and, in some cells, in the gray matter of the cervical segments of the spinal cord (Fig. 3C) , whereas no labeled cells could be detected with the rMAL cRNA probe (Fig. 3B ). At this developmental stage, only traces of the glycolipid antigen 01 and of MBP immunoreactivity, both specifically expressed by oligodendrocytes and Schwann cells (Sommer and Schachner, 1981; Colman et al., 1982) , were detectable in a small region of the ventral funiculus (Rozeik and Keyserlingk, 1987; Schwab and Schnell, 1989) . The first oligodendrocytes expressing rMAL mRNAs could be detected in the ventral funiculi of half-day-old animals. In the PNS, transcripts for rMAL and MBP were detectable in Schwann cells of the ventral and dorsal roots of the newborn spinal cord (Fig. 3B,C, respectively) .
In situ hybridization on sagittal sections of a newborn rat head (Fig. 30 ) demonstrated that rMAL mRNA was not detectable in the newborn CNS (Fig. 3E) , in contrast to MBP mRNA which is expressed in the brainstem, in the developing white matter of the cerebellum and in a few single cells in the corpus callosum (Fig. 3F) .
In the trigeminal nerve, as in the cervical spinal roots, rMAL was detectable over the whole nerve with a decreasing expression level towards the whisker pad (Fig. 3E ), similar to, although at lower levels than MBP mRNA (Fig. 3F) .
At P5, rMAL mRNA is highly expressed in the myelinating jiber tracts of the nervous system In situ hybridization for rMAL and MBP mRNA was combined with MBP immunofluorescence on cross sections of postnatal day 5 spinal cord ( Fig. 4A-C) . Similar to PO, rMAL was expressed by cells in the developing CNS white matter and spinal roots (Fig. 4B) . The number of rMAL-positive cells was clearly lower than that of MBP-positive cells (Fig. 4C) , suggesting that the expression of the rMAL gene follows that of MBP.
In sagittal brain sections, rMAL mRNA was detectable in the developing white matter of brainstem and cerebellum (Fig. 40) regions where myelination is known to be most advanced (Jacobson 1963) . In corpus callosum, rMAL mRNA could not be detected (Fig. 4F) , whereas MBP mRNA is already highly expressed (Fig. 4G) .
At P15, rMAL mRNA is highly expressed in all myelinating regions of the nervous system In postnatal day 15 spinal cords, expression of the oligodendrocyte-specific genes such as MBP and rMAL was most prominent as shown by Northern blot analysis ( Fig. 2B ; Zeller et al., 1984) . In situ hybridization showed that rMAL and MBP mRNAs were highly expressed in oligodendrocytes and in Schwann cells (Schaeren-Wiemers et al., 1995) . Again, however, the expression of rMAL seemed to lag behind that of MBP; In P15 brain sections MBP mRNA was already detectable in regions which are less myelinated such as the granule cell layer of the cerebellum and the cerebral cortex, whereas transcripts of rMAL were only detectable in myelinating fiber tracts of the white matter (not shown).
In the adult spinal cord, rMAL mRNA is more highly expressed in oligodendrocytes of the gray matter than of the white matter Interestingly, in situ hybridization in the spinal cord demonstrated that the expression of rMAL mRNA is higher in oligodendrocytes of the gray matter than of the white matter (Fig. 5A,C ) in contrast to MBP mRNA (Fig. 5B) and several other oligodendrocyte-specific genes (data not shown) that are more highly expressed in oligodendrocytes of the white matter. In the brain the expression level of rMAL transcripts was similar in white and gray matter: oligodendrocytes in the cerebral cortex and in the granule cell layer of the cerebellum were as intensely labeled with the rMAL probe as oligodendrocytes lying in the neighboring myelinated fiber tracts (Fig. 5D,F) , comparable to the pattern seen for MBP mRNA (Fig. 5&G) .
rMAL-protein is localized in PNS and CNS myelin To investigate the cellular localization of the rMAL protein, polyclonal rabbit antisera were raised against peptides derived from the rMAL amino acid sequence. The best results were obtained with an anti-peptide antiserum directed against amino acid 114-126 forming the third putative extracellular domain of the rMAL protein. With this serum, a specific band was obtained in the 18-20 kDa range on immunoblots from CNS myelin proteins (Fig. 6) . This antiserum was then used for immunohistochemistry on frozen sections of nervous tissue (Figs. 7, 8) .
In spinal roots, rMAL immunoreactivity was observed in the myelin sheaths (Fig. 7A) . The staining pattern corresponded to the staining pattern of MBP (Fig. 7B ). The differences in staining intensity of different nerve fibers probably reflect differences in myelination or antibody penetration, since similar results were obtained with an anti-MBP staining.
On cross sections of adult spinal cord, highest rMAL immunoreactivity was detected in the myelinated regions, for example, in the dorsal funiculus (Fig. 70) . In comparison to MBP rMAL immunoreactivity was higher in the PNS part of the spinal roots than in the part myelinated by oligodendrocytes (Fig. 7D,E) .
On sagittal sections of adult brain, rMAL immunoreactivity was localized in the myelinated regions as exemplified by the cerebellum (Fig. 8A) . Compared to an anti-MBP antiserum, the immunoreactivity for the rMAL anti-peptide antiserum was weaker (Fig. 8s) .
Discussion
In this report, we describe the characterization of a rat cDNA that encodes an new myelin protein with four putative transmembrane domains. This cDNA is called rMAL since it is most probably the rat homolog of a human cDNA (MAL) isolated from human T-cell lines (Alonso and Weissman, 1987) . The rMAL gene is predominantly expressed in myelinated areas of the CNS and PNS, with a higher expression level in the PNS. The onset of rMAL expression correlates well with myelin formation by oligodendrocytes and Schwann cells: the rMAL gene starts to be expressed just before birth in Schwann cells and after birth in oligodendrocytes of brainstem and spinal cord. The developmental expression pattern of rMAL transcripts corresponds to that of the glycolipid marker 01 and of MBP but is delayed compared to MBP mRNA expression which is already detectable in Schwann cells at embryonic day E17.5 and in oligodendrocytes before birth (own observations).
In comparison to other recently identified oligodendrocyteand myelin-specific genes (Schaeren-Wiemers et al., 1995) rMAL is a late gene in developing oligodendrocytes. Most of the myelin genes studied so far including MBP are more highly expressed in oligodendrocytes of the white matter than of the gray matter (Jordan et al., 1989 ; our own observations). Interestingly, the rMAL gene appears to be an exception: in the oligodendrocytes of the gray matter of the adult spinal cord, the expression level of the rMAL gene is consistently higher than in the adjacent white matter regions.
Evidence that the rMAL protein is a myelin protein was obtained by immunohistochemistry and immunoblots using a rMAL-specific anti-peptide antiserum. rMAL immunoreactivity could be localized in the myelinated areas in the brain, in spinal cord, and in myelin sheaths of spinal roots. The levels of rMAL protein in the PNS were higher than in the CNS similar to the levels of rMAL mRNA. Compared to MBP a major myelin protein which constitutes up to 30% of the total CNS myelin protein, staining for rMAL was clearly weaker. Results from immunoblots show rMAL immunoreactivity in a 18-20 kDa pro- tein band which was not detected by the preimmune serum. As it is known for other myelin proteins, rMAL was enriched in the myelin fractions (unpublished observation).
Relationship of rat MAL to the human gene MAL
Sequence analysis of the NS 3 cDNA clone showed a very high homology to a human gene called MAL that was isolated by subtractive hybridization of two different human T-cell lines (Alonso and Weissman, 1987) . Within the open reading frame the two cDNAs show a 89% identity on the amino acid level and 80% identity on the nucleotide level. At the 3' nontranslated end, however, rat MAL has a 1.2 kb extension, which is absent in human MAL. The human MAL gene is expressed in leukemic T-cell lines that express both the T-cell receptor and the Tll antigen, and in normal mature T-cell clones (Alonso and Weissman, 1987) . Genomic Southern analysis with rMAL on chromosomal rat DNA revealed a similar hybridization pattern as it has been shown with the human MAL probe hybridized on rat chromosomal DNA (data not shown, Alonso et al., 1988) . Therefore, it is very likely that NS 3 is the rat homolog to human MAL. For this reason, we propose to call this protein rMAL, standing for rat Myelin And Lymphocyte protein.
Northern analysis of adult human tissues showed that MAL is expressed in thymus, but not in colon, liver, adrenal gland, and in cells from B-cell lines (Alonso and Weissman, 1987) . Our data show that the rMAL gene is predominantly expressed in the nervous system, especially during myelination. In spleen and kidney rMAL transcripts could also be detected but at a much lower level. Since Northern analysis for MAL has not been performed in those tissues from humans, a direct comparison can not be made.
drocytes of the gray matter than of the white matter (C). In situ hybridization on sagittal sections of the cerebellum (D) or the corpus callosum (F) show that rMAL mRNA is highly expressed in oligodendrocytes of the white and of the gray matter. E and G, Serial sections stained for MBP mRNA. wt, white matter; gr, gray matter; gel, granule cell layer; vr, ventral root. Scale bar: A, B, D, and E, 530 pm; C, 190 pm; F and G, 116 km. A. r MAL Figure   8 . Localization of rMAL protein in the cerebellum. Immunoperoxidase detection of rMAL protein was performed with anti-rMAL peptide antiserum on sagittal sections of adult cerebellum (A, brightfield micrograph). rMAL immunoreactivity was confined to the white matter and to the myelinated fibers in the granule cell layer. In B, the myelin pattern is shown by immunoperoxidase detection of MBP on an adjacent cerebellar section. Scale bar: A and B, 380 pm.
Structural relationship of rMAL to other four-hydrophobic domain proteins Although there are no obvious amino acid sequence homologies between rMAL and other proteins, the predicted protein showed interesting structural features. The putative rMAL protein belongs to the superfamily of four-hydrophobic domain proteins. This family includes the myelin proteins PLP/DM 20 and DMo, DMB and DMy (for review, see Kitagawa et al., 1993) ; the PLPrelated protein M6 (Yan et al., 1993) ; PMP-22 (Suter et al., 1992) ; the gap junction proteins of the connexin superfamily (Bennett et al., 1991) ; the ion channels nAChR, GluR, GABA-, NMDA-, and glycine receptor (for review, see Unwin, 1989) ; and others like the retinal photoreceptor protein peripherin-rds (Travis et al., 1991) and rom-1 (Bascom et al., 1992) and the lymphocyte antigen CD9 (Boucheix et al., 1991) . It is not known yet whether all four hydrophobic domains of the MAL protein span the bilayer with the C-and N-terminus on the cytoplasmic side of the membrane. Recent investigations of the transmembrane topology of the glutamate receptor GluRl suggest that the four hydrophobic regions of this protein can, in fact, have different orientations; of four transmembrane domains of GluRl only three span the bilayer (Hollmann et al., 1994) .
While PLP is predominantly localized in compact CNS myelin, PMP-22 expression is restricted to compact PNS myelin. Mutations of PLP cause massive myelin disorders in the CNS like in the jimpy and rumpshaker mouse, the myelin deficient rat and in Pelizaeus-Merzbacher disease in humans (Schneider et al., 1992) . Mutations in the PMP-22 gene causes degenerative disorders in the PNS in the trembler mouse and Charcot-MarieTooth 1A disease in humans (Suter et el., 1993) . Interestingly, most of the PLP and PMP-22 mutations that give rise to these serious neurological phenotypes are found in the transmembrane domains showing the important functional significance of these membrane-spanning regions. The main function of PLP seems to lay in the compaction of the extracellular part of the myelin lamellae, as this process is typically disturbed in these mutations. Since the putative rMAL protein is expressed in the myelinating cells of the CNS and PNS and shares important structural features with PLP and PMP-22, it may play an important role in central and peripheral myelin formation.
In contrast to PLP and PMP-22, the first and third putative transmembrane domain of the rMAL protein carries charged amino acids which lead to an amphipathic character of these segments. This structural feature is known from the gap junction proteins of the connexin family and from ion channel proteins (for review see Unwin, 1989 ) and CD9 (Boucheix et al., 1991) . The polar amino acids of the third transmembrane domains of the connexins are thought to form the wall of the gap junction channel (Milks et al., 1988) which permits the passage of water soluble molecules. Connexins are four-transmembrane domain proteins which lack a cleavable signal peptide and are not glycosylated, similar to rMAL. So far, one member of the connexin superfamily, connexin 32 (Cx32), could be localized in oligodendrocytes and Schwann cells (Bergoffen et al., 1993) . Mutations in the human Cx32 gene have been linked to CharcotMarie-Tooth disease type X (CMTX), a hereditary form of peripheral neuropathy. Although Cx32 is present also in liver, epithelial cells, some CNS neurons and oligodendrocytes (Bennett et al., 1991) , the manifestations of CMTX appear to be limited to peripheral nerves. This suggests that a malfunction of Cx32 can be compensated for by other proteins except in peripheral myelin.
The correlation of the rMAL gene expression with the expression of several other myelin genes, the localization of rMAL protein in myelin sheaths and the similarity of rMAL protein to other myelin proteins with four hydrophobic domains point to a role of this highly hydrophobic membrane protein in myelin formation. Alternatively, rMAL could form or participate in the formation of channels or pores for the passage of small molecules. The possible relation of this new myelin protein to neuropathies of so far unknown origin, for example, CMTIC, should also be considered.
